Gault Cheryl — SEC insider filings
SEC reporting owner CIK 1839046. 12 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2021-12-10 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 6 filings — 42,014 shares, $1,429,913 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 7,925 shares @ $33.04 ($261,813) in Rapport Therapeutics, Inc., filed 2026-10-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Chief Operating Officer | 10 | — | 11 legs · 42,014 sh · $1,429,913 | 8 |
| Cyclerion Therapeutics, Inc. (CYCN) | Chief Operating Officer | 2 | — | — | 2 |
Insider filings — Gault Cheryl
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 7,925 @ $33.04 · Sale (S): 2,075 @ $33.76 | EDGAR |
| 2026-07-01 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 1,900 @ $40.09 · Sale (S): 3,792 @ $41.39 · Sale (S): 3,308 @ $42.17 · Sale (S): 1,000 @ $43.15 | EDGAR |
| 2026-03-31 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 7,161 @ $28.04 · Sale (S): 2,839 @ $28.55 | EDGAR |
| 2026-03-09 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 2,014 @ $28.93 | EDGAR |
| 2026-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 132,000 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Rapport Therapeutics, Inc. (RAPP) | Option exercise (M): 5,000 @ $1.80 · Sale (S): 5,000 @ $30.10 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Option exercise (M): 5,000 @ $1.80 · Sale (S): 5,000 @ $38.33 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 13,987 @ $0 | EDGAR |
| 2025-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 129,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 88,442 (derivative) @ $0 | EDGAR |
| 2022-01-24 | 4 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2021-12-10 | 4 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-12-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1839046 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs